Cargando…
No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210164/ https://www.ncbi.nlm.nih.gov/pubmed/32395560 http://dx.doi.org/10.21037/atm.2020.01.26 |
| _version_ | 1783531225405718528 |
|---|---|
| author | Valgimigli, Marco Gragnano, Felice |
| author_facet | Valgimigli, Marco Gragnano, Felice |
| author_sort | Valgimigli, Marco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7210164 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72101642020-05-11 No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI Valgimigli, Marco Gragnano, Felice Ann Transl Med Editorial Commentary AME Publishing Company 2020-04 /pmc/articles/PMC7210164/ /pubmed/32395560 http://dx.doi.org/10.21037/atm.2020.01.26 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Valgimigli, Marco Gragnano, Felice No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI |
| title | No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI |
| title_full | No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI |
| title_fullStr | No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI |
| title_full_unstemmed | No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI |
| title_short | No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI |
| title_sort | no free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after acs or pci |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210164/ https://www.ncbi.nlm.nih.gov/pubmed/32395560 http://dx.doi.org/10.21037/atm.2020.01.26 |
| work_keys_str_mv | AT valgimiglimarco nofreelunchthepriceofdoubleversustripleantithrombotictherapyinpatientswithatrialfibrillationafteracsorpci AT gragnanofelice nofreelunchthepriceofdoubleversustripleantithrombotictherapyinpatientswithatrialfibrillationafteracsorpci |